Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.3 - $6.29 $306,590 - $838,457
-133,300 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$4.63 - $9.94 $36,577 - $78,526
-7,900 Reduced 5.59%
133,300 $763,000
Q4 2021

Feb 11, 2022

BUY
$8.35 - $12.6 $1.18 Million - $1.78 Million
141,200 New
141,200 $1.29 Million
Q2 2021

Aug 16, 2021

SELL
$13.27 - $18.48 $1.18 Million - $1.64 Million
-88,600 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$14.49 - $20.72 $414,414 - $592,592
28,600 Added 47.67%
88,600 $1.44 Million
Q1 2020

May 15, 2020

BUY
$10.23 - $24.56 $613,800 - $1.47 Million
60,000 New
60,000 $703,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $227M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.